Method to treat cancer with tetracyclines
OwnerRose S. Fife, George W. Sledgeinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides a method to treat susceptible cancers in humans comprising administering a cancer-treating amount of a member of the tetracycline family or a pharmaceutically acceptable salt thereof. Doxycycline, minocycline and tetracycline are utilized in the preferred method. Preferred methods of the present invention treat osteo-, breast, lung, prostate or Kaposi's cancers. Other aspects of the invention are described in the full application.
Claims12
A method to inhibit migration of TCN-sensitive cancer cells without curing the underlying tumor in a human who has identified cancer and is in need of cell migration inhibition, comprising administering to said human a cell migration-inhibiting amount of a tetracycline (TCN) or a pharmaceutically acceptable salt thereof.
A method for treating a human genetically or environmentally susceptible to migration of TCN-sensitive cancer cells, comprising administering to said human a cancer cell migration-preventing amount of a tetracycline (TCN) or a pharmaceutically acceptable salt thereof without curing the underlying tumor.
Dependencies are inferred from the claim text.